XML 91 R43.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Earnings Per Common Share (Tables)
 12 Months Ended
Dec. 31, 2019
Earnings Per Share [Abstract]  
Schedule of computation of basic and diluted earnings per share (in thousands, except per share amounts)
The following table illustrates the computation of basic and diluted earnings per share (in thousands, except per share amounts):
 
Year Ended December 31,
 
2019
 
2018
 
2017
Numerator
 
 
 
 
 
Net income (loss)
$
60,061

    
$
1,073,474

 
$
422,634

Noncontrolling interests' share in earnings
(14,531
)
 
(12,381
)
 
(8,465
)
Net income (loss) attributable to Healthpeak Properties, Inc.
45,530

 
1,061,093

 
414,169

Less: Participating securities' share in earnings
(1,543
)
 
(2,669
)
 
(1,156
)
Net income (loss) applicable to common shares
$
43,987

 
$
1,058,424

 
$
413,013

 
 
 
 
 
 
Numerator - Dilutive
 
 
 
 
 
Net income (loss) applicable to common shares
$
43,987

 
$
1,058,424

 
$
413,013

Add: distributions on dilutive convertible units and other
—

 
6,919

 
—

Dilutive net income (loss) available to common shares
$
43,987

 
$
1,065,343

 
$
413,013

Denominator
 
 
 
 
 
Basic weighted average shares outstanding
486,255

 
470,551

 
468,759

Dilutive potential common shares - equity awards
309

 
168

 
176

Dilutive potential common shares - forward equity agreements(1)
2,771

 
—

 
—

Dilutive potential common shares - DownREIT conversions
—

 
4,668

 
—

Diluted weighted average common shares
489,335

 
475,387

 
468,935

Earnings per common share


 


 


Basic
$
0.09

 
$
2.25

 
$
0.88

Diluted
$
0.09

 
$
2.24

 
$
0.88


(1)
Represents the current dilutive impact of 30 million shares of common stock under forward sales agreements that have not been settled as of December 31, 2019. Based on the forward price of each agreement as of December 31, 2019, issuance of all 30 million shares would result in approximately $1.00 billion of net proceeds.